Merck KGaA (OTCMKTS:MKGAF) Trading Down 3.8% - Time to Sell?

Key Points

• Merck KGaA's share price fell by 3.8% during mid-day trading, closing at $132.31, following a previous close of $137.51.
• The company's market capitalization is $17.55 billion with a P/E ratio of 20.74 and a quick ratio of 0.84.
• Merck KGaA operates in various segments including Life Science, Healthcare, and Electronics, providing tools and chemicals for labs and industrial sectors.

Merck KGaA (OTCMKTS:MKGAF - )'s share price traded down 3.8% during mid-day trading on Monday . The company traded as low as $132.31 and last traded at $132.31. 1,139 shares were traded during trading, an increase of 18% from the average session volume of 968 shares. The stock had previously closed at $137.51.

Merck KGaA Stock Down 1.2%

The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $17.55 billion, a P/E ratio of 20.74 and a beta of 0.96. The firm has a 50-day moving average price of $130.39 and a two-hundred day moving average price of $132.05.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.